Evidence map›Paper›PMID 26811476›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

A structured interdomain linker directs self-polymerization of human uromodulin.

Marcel Bokhove, Kaoru Nishimura, Martina Brunati, Ling Han, Daniele de Sanctis, Luca Rampoldi, Luca Jovine

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 103 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. The role of uromodulin in cardiovascular disease: a review.Frontiers in cardiovascular medicine · 2024
    Review
  13. Biomolecules · 2023
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Role of Uromodulin in Salt-Sensitive Hypertension.Hypertension (Dallas, Tex. : 1979) · 2022
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Marcel BokhoveDepartment of Biosciences and Nutrition & Center for Innovative Medicine, Karolinska Institutet, SE-141 83 Huddinge, Sweden;
Kaoru NishimuraDepartment of Biosciences and Nutrition & Center for Innovative Medicine, Karolinska Institutet, SE-141 83 Huddinge, Sweden;
Martina BrunatiMolecular Genetics of Renal Disorders Unit, Division of Genetics and Cell Biology, San Raffaele Scientific Institute, I-20132 Milan, Italy;
Ling HanDepartment of Biosciences and Nutrition & Center for Innovative Medicine, Karolinska Institutet, SE-141 83 Huddinge, Sweden;
Daniele de SanctisEuropean Synchrotron Radiation Facility - The European Synchrotron, Grenoble 38000, France.
Luca RampoldiMolecular Genetics of Renal Disorders Unit, Division of Genetics and Cell Biology, San Raffaele Scientific Institute, I-20132 Milan, Italy;
Luca JovineDepartment of Biosciences and Nutrition & Center for Innovative Medicine, Karolinska Institutet, SE-141 83 Huddinge, Sweden; luca.jovine@ki.se.ORCID http://orcid.org/0000-0002-2679-6946
Karolinska Institutet · SEEuropean Synchrotron Radiation Facility · FR

Funding

European Research Council 260759Telethon GGP14263
6 · The paper itself

Abstract

Uromodulin (UMOD)/Tamm-Horsfall protein, the most abundant human urinary protein, plays a key role in chronic kidney diseases and is a promising therapeutic target for hypertension. Via its bipartite zona pellucida module (ZP-N/ZP-C), UMOD forms extracellular filaments that regulate kidney electrolyte balance and innate immunity, as well as protect against renal stones. Moreover, salt-dependent aggregation of UMOD filaments in the urine generates a soluble molecular net that captures uropathogenic bacteria and facilitates their clearance. Despite the functional importance of its homopolymers, no structural information is available on UMOD and how it self-assembles into filaments. Here, we report the crystal structures of polymerization regions of human UMOD and mouse ZP2, an essential sperm receptor protein that is structurally related to UMOD but forms heteropolymers. The structure of UMOD reveals that an extensive hydrophobic interface mediates ZP-N domain homodimerization. This arrangement is required for filament formation and is directed by an ordered ZP-N/ZP-C linker that is not observed in ZP2 but is conserved in the sequence of deafness/Crohn's disease-associated homopolymeric glycoproteins α-tectorin (TECTA) and glycoprotein 2 (GP2). Our data provide an example of how interdomain linker plasticity can modulate the function of structurally similar multidomain proteins. Moreover, the architecture of UMOD rationalizes numerous pathogenic mutations in both UMOD and TECTA genes.

Indexed as

PolymerizationAmino Acid SequenceAnimalsBlotting, WesternCrystallography, X-RayDisulfidesDogsExtracellular Matrix ProteinsFluorescent Antibody TechniqueGPI-Linked ProteinsHEK293 CellsHumansMadin Darby Canine Kidney CellsMaltose-Binding ProteinsMiceModels, MolecularDisulfidesExtracellular Matrix ProteinsGPI-Linked ProteinsMaltose-Binding ProteinsRecombinant Fusion ProteinsTECTA protein, humanUromodulinpolymerizationuromodulinX-ray crystallographyzona pellucida domainZP2

Identifiers

PMID26811476
PMCPMC4760807
OpenAlexW2263502853

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.